I continue to think Monsanto (NYSE:MON) is a solid buy around here, despite the early unexpected weakness in the name.
My logic tells me people will want to position themselves ahead of the investor meeting as knowing MON we are likely going to get some nice headlines from there.
MON @ $105 here.
PS: The other AG's look overextended to the downside as well. POT in particular.
My logic tells me people will want to position themselves ahead of the investor meeting as knowing MON we are likely going to get some nice headlines from there.
MON @ $105 here.
PS: The other AG's look overextended to the downside as well. POT in particular.
No comments:
Post a Comment